Patricia Gaule

1.5k total citations
29 papers, 1.0k citations indexed

About

Patricia Gaule is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Patricia Gaule has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 12 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Patricia Gaule's work include Cancer Immunotherapy and Biomarkers (12 papers), HER2/EGFR in Cancer Research (8 papers) and Immunotherapy and Immune Responses (5 papers). Patricia Gaule is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), HER2/EGFR in Cancer Research (8 papers) and Immunotherapy and Immune Responses (5 papers). Patricia Gaule collaborates with scholars based in United States, Ireland and United Kingdom. Patricia Gaule's co-authors include David L. Rimm, Kurt A. Schalper, Mehmet Altan, Roy S. Herbst, Maria Toki, John Crown, Lieping Chen, Norma O’Donovan, Miguel F. Sanmamed and James W. Smithy and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Patricia Gaule

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia Gaule United States 13 665 344 269 221 187 29 1.0k
In Ah Park South Korea 19 765 1.2× 550 1.6× 252 0.9× 137 0.6× 215 1.1× 28 1.1k
Rilan Bai China 13 567 0.9× 306 0.9× 240 0.9× 247 1.1× 171 0.9× 36 920
Ecaterina E. Dumbrava United States 17 647 1.0× 185 0.5× 379 1.4× 218 1.0× 194 1.0× 115 1.0k
Stephen J. Luen Australia 13 958 1.4× 453 1.3× 290 1.1× 354 1.6× 307 1.6× 32 1.3k
Shaveta Vinayak United States 15 790 1.2× 193 0.6× 429 1.6× 239 1.1× 351 1.9× 45 1.2k
Gert Van den Eynden Belgium 17 861 1.3× 445 1.3× 400 1.5× 289 1.3× 381 2.0× 34 1.3k
Luigi Manenti United States 10 470 0.7× 284 0.8× 332 1.2× 115 0.5× 171 0.9× 20 886
Barbara Mino United States 18 620 0.9× 217 0.6× 458 1.7× 254 1.1× 225 1.2× 27 1.1k
Lucia Festino Italy 18 880 1.3× 375 1.1× 368 1.4× 190 0.9× 109 0.6× 39 1.2k
Ana Carneiro Sweden 16 650 1.0× 272 0.8× 467 1.7× 203 0.9× 145 0.8× 46 1.1k

Countries citing papers authored by Patricia Gaule

Since Specialization
Citations

This map shows the geographic impact of Patricia Gaule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Gaule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Gaule more than expected).

Fields of papers citing papers by Patricia Gaule

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Gaule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Gaule. The network helps show where Patricia Gaule may publish in the future.

Co-authorship network of co-authors of Patricia Gaule

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Gaule. A scholar is included among the top collaborators of Patricia Gaule based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Gaule. Patricia Gaule is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aung, Thazin Nwe, et al.. (2025). Quantitative assessment of HER2 expression in invasive ductal carcinoma and co-existing DCIS. Breast Cancer Research and Treatment. 213(2). 273–279.
2.
Cho, Christina, et al.. (2025). PD-1H (VISTA) Expression in Cutaneous Squamous Cell Carcinoma Is Correlated with T-Cell Infiltration and Activation. Journal of Investigative Dermatology. 145(9). 2313–2324.e6.
3.
Gaule, Patricia, et al.. (2025). Validation and Prospective Testing of a High-Sensitivity, Quantitative Analytic Assay for HER2 on Histopathology Slides. Laboratory Investigation. 105(12). 104233–104233. 2 indexed citations
4.
5.
Fernandez, Aileen I., Patricia Gaule, & David L. Rimm. (2023). Tissue Age Affects Antigenicity and Scoring for the 22C3 Immunohistochemistry Companion Diagnostic Test. Modern Pathology. 36(7). 100159–100159. 10 indexed citations
6.
Vesely, Matthew D., Patricia Gaule, Swati Gupta, et al.. (2023). Immune Inhibitory Molecule PD-1 Homolog (VISTA) Colocalizes with CD11b Myeloid Cells in Melanoma and Is Associated with Poor Outcomes. Journal of Investigative Dermatology. 144(1). 106–115.e4. 5 indexed citations
7.
Roche, Sandra, Patricia Gaule, Nupur Mukherjee, et al.. (2023). Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer. PLoS ONE. 18(3). e0282512–e0282512. 6 indexed citations
8.
Moutafi, Myrto, Charles T. Robbins, Vesal Yaghoobi, et al.. (2022). Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer. Laboratory Investigation. 102(10). 1101–1108. 91 indexed citations
9.
Cai, Yuping, Xinyi Shen, Lingeng Lu, et al.. (2022). Bile acid distributions, sex-specificity, and prognosis in colorectal cancer. Biology of Sex Differences. 13(1). 61–61. 24 indexed citations
10.
Muthusamy, Viswanathan, et al.. (2021). Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes. Cancer Research. 81(16). 4346–4359. 41 indexed citations
11.
Ahmed, Fahad Shabbir, Patricia Gaule, John J. McGuire, et al.. (2020). PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast Cancer. Clinical Cancer Research. 26(20). 5456–5461. 67 indexed citations
12.
Breen, Laura, Patricia Gaule, Alexandra Canonici, et al.. (2020). Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A. Investigational New Drugs. 38(5). 1365–1372. 10 indexed citations
13.
Han, Xue, Matthew D. Vesely, Wendy Yang, et al.. (2019). PD-1H (VISTA)–mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus. Science Translational Medicine. 11(522). 101 indexed citations
14.
Gaule, Patricia, Nupur Mukherjee, B. Corkery, et al.. (2019). Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells. Cancers. 11(4). 548–548. 19 indexed citations
15.
Vesely, Matthew D., Patricia Gaule, & Lan Chen. (2019). 843 Immune checkpoint molecule PD-1H/VISTA expression correlates with melanoma survival. Journal of Investigative Dermatology. 139(5). S145–S145. 2 indexed citations
16.
Altan, Mehmet, Vasiliki Pelekanou, Kurt A. Schalper, et al.. (2017). B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes. Clinical Cancer Research. 23(17). 5202–5209. 108 indexed citations
17.
Smithy, James W., Vasiliki Pelekanou, Jamaal Rehman, et al.. (2017). Nuclear IRF-1 expression as a mechanism to assess “Capability” to express PD-L1 and response to PD-1 therapy in metastatic melanoma. Journal for ImmunoTherapy of Cancer. 5(1). 25–25. 30 indexed citations
18.
Schalper, Kurt A., Daniel Carvajal‐Hausdorf, Joseph McLaughlin, et al.. (2016). Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer. Clinical Cancer Research. 23(2). 370–378. 160 indexed citations
19.
Gaule, Patricia, John Crown, Norma O’Donovan, & Michael J. Duffy. (2014). cMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients?. Expert Opinion on Therapeutic Targets. 18(9). 999–1009. 26 indexed citations
20.
Madden, Stephen F., Colin Clarke, Patricia Gaule, et al.. (2013). BreastMark: An Integrated Approach to Mining Publicly Available Transcriptomic Datasets Relating to Breast Cancer Outcome. Breast Cancer Research. 15(4). R52–R52. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by In Ah Park Breakdown of academic impact, for papers by Rilan Bai Breakdown of academic impact, for papers by Ecaterina E. Dumbrava Breakdown of academic impact, for papers by Stephen J. Luen Breakdown of academic impact, for papers by Shaveta Vinayak Breakdown of academic impact, for papers by Gert Van den Eynden Breakdown of academic impact, for papers by Luigi Manenti Breakdown of academic impact, for papers by Barbara Mino Breakdown of academic impact, for papers by Lucia Festino Breakdown of academic impact, for papers by Ana Carneiro
Rankless by CCL
2026